Investors Notified of Class Action Lawsuits Against ASRT and VNET by Bragar Eagel & Squire, P.C.

NEW YORK—In a significant development for shareholders, the law firm Bragar Eagel & Squire, P.C., recognized for defending shareholder rights, has issued a reminder about the initiation of class action lawsuits on behalf of investors of VNET, 21Vianet Group, Inc., and ASRT, Assertio Holdings, Inc. The legal pursuits have been catalyzed by allegations against the two companies concerning probable breaches of federal securities laws.

Overview of Assertio Holdings, Inc. ASRT

Headquartered in Lake Forest, Illinois, Assertio Holdings, Inc. ASRT is a pharmaceutical company focused on the commercialization of drugs targeting neurology, hospital settings, and pain and inflammation management. This focus has paved the way for ASRT to establish a notable presence in the pharmaceutical industry.

Overview of 21Vianet Group, Inc. VNET

VNET, 21Vianet Group, Inc., operates as an investment holding entity, providing hosting and related services to diversified clientele including Internet companies, government entities, esteemed blue-chip enterprises, as well as small to medium-sized businesses within the People's Republic of China. With headquarters in Beijing, VNET plays a vital role in China's Internet infrastructure landscape.

The class action lawsuits brought forth signal a heightened level of scrutiny on the practices and disclosures of both ASRT and VNET, and are indicative of broader accountability trends in the investment world. Investors who have been affected are being urged by Bragar Eagel & Squire, P.C. to come forward and participate in the lawsuit to potentially recuperate their financial losses.

Investors, ClassAction, Lawsuit